Why is Surgery Partners stock surging today?

Surgery Partners stock surged nearly 10% in pre-open trading today after the company released its third-quarter 2026 financial results before the market opened, with a conference call scheduled for 8:30 AM ET. The pre-market price of $25.50 — notably above the $23.50-per-share cash merger price announced just two weeks ago — suggests the quarterly results came in ahead of Wall Street’s consensus expectations of approximately $0.11 in earnings per share on roughly $829 million in revenue, stoking optimism among investors.

The broader deal backdrop has been a key driver of SGRY’s elevated trading range in recent weeks. On October 26, 2026, HealthSpan Partners, an affiliate of Bon Secours Mercy Health, agreed to acquire Surgery Partners in an all-cash transaction valued at approximately $5.7 billion in enterprise value, offering public shareholders $23.50 per share — a roughly 49% premium to the stock’s prior close. Bain Capital, which holds approximately 39% of outstanding shares, is rolling over its equity into the post-merger entity rather than being cashed out alongside public stockholders, a structure that has drawn scrutiny from multiple law firms today, including a fiduciary duty investigation announced this morning.

The broader U.S. equity market is providing a constructive backdrop, with the S&P 500 up 0.9%, the Dow Jones Industrial Average up 1.3%, and the Nasdaq Composite up 0.8%. The healthcare services sector, in which Surgery Partners operates ambulatory surgery centers and surgical hospitals across the country, has benefited from the general risk-on tone in markets today.

Taken together, a pre-market earnings release that appears to have exceeded analyst forecasts, combined with the lingering premium-deal dynamics and a positive macro environment, has created the conditions for today’s outsized pre-market move, pushing shares well above both their 52-week high of $23.37 and the stated merger consideration of $23.50 per share.